期刊文献+

腹膜透析与代谢综合征发病及影响因素分析 被引量:6

下载PDF
导出
摘要 腹膜透析是终末期肾脏病(end-stage of renal disease,ESRD)患者重要的肾脏替代疗法之一。在我国已被越来越多的医生及ESRD患者接受。腹膜透析(PD)主要有以下几方面的优点:操作简单方便、无需肝素化、患者内环境相对稳定、保护残余肾功能,尤其适用于老年、
出处 《中国中西医结合肾病杂志》 2012年第2期159-161,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 哈尔滨市科技局基金资助项目(No.2012RFXXS001)
  • 相关文献

参考文献3

二级参考文献14

  • 1俞雨生,韩国锋,沈克勤,樊荣,胡伟新,姚小丹,唐政,黎磊石.残余肾功能对腹膜透析的影响[J].肾脏病与透析肾移植杂志,1996,5(4):31-35. 被引量:41
  • 2王海燕 郑法雷 等.原发性肾小球疾病分型与治疗及诊断标准座谈会纪要[J].中华内科杂志,1993,32(3):131-134.
  • 3傅祖植.血脂异常和脂蛋白异常血症[A].陈灏珠主编.内科学第6版[M].北京:人民卫生出版社,2004.821-831.
  • 4Mckane W,Chandna SM,Tattersall JE,et al.Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD.Kidney Int,2002,61(1):256-265.
  • 5National kidney foundation K/DOQI dinical practice guidelines for peritoneal dialysis adequacy:update 2000.Am J Kidney Dis,2001,37(Suppl 1):S65-S136.
  • 6Carofei O,Taratufolo A,Atti S,et al.Residual renal function and post dialysis urea rebound.EDTNA ERCA J,1999,25(2):7-8.
  • 7No authors listed.The 6th report of joint national committee on prevention,detection,evaluation,and treatment of high blood pressure.Arch Intern Med,1997,157(21):2413-2446.
  • 8Heimburger O.Residual renal function,peritoneal transport characteristics and dialysis adequacy in peritoneal dialysis.Kidney Int Suppl,1996,56:S47-S55.
  • 9No authors listed.Adequacy of dialysis and nutrition in continuous peritoneal dialysis:association with clinical outcomes.J Am Soc Nephrol,1996,7(2):198-207.
  • 10Schwarz U,Buzello M,Ritz E,et al.Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure.Nephrol Dial Transplant,2000,15(2):218-230.

共引文献140

同被引文献85

  • 1颜佳毅,张敏芳,倪兆慧,殷焱,牟姗,王琴,方炜,朱铭力,张伟明,严玉澄,钱家麒.中晚期慢性肾脏病患者冠状动脉钙化的发生情况及影响因素分析[J].中国血液净化,2012,11(1):13-17. 被引量:12
  • 2李学旺,李航.炎症是脂质异常介导的动脉粥样硬化和肾脏损害的中心环节[J].中华肾脏病杂志,2005,21(9):499-501. 被引量:34
  • 3Hanley A J, Williams K, Sttem MP, et al. Homeostasis model assess- ment of insulin resistance in relation to the incidence of cardiovas- cular disease:the san Antonio heart study[ J]. Diabetes Care,2002, 25:1177 - 1184.
  • 4Bergstrom J,Furst P,Alvestrand A,et al. Pretein and energy intake,ni- trogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis[J]. Kidney Int,1993,44 : 1048 - 1057.
  • 5Fortes PC, De Moraes TP, Mendes JG,et al. Insul in resistance and glucose homeostasis in peritoneal dialysis[ J]. Petit Dial Int,2009, 29(Suppl 2) :145 - 148.
  • 6Locatelli F, Covic A, Chazot C, et al, Optimal composition of the di- alysate,with emphasis on its influence on blood pressure [J]. Nephrol Dial Transplant,2004,19 (4) : 785 - 796.
  • 7Jackson MA, Holland MR, Nicholas J, et al. Occult hypoglycemia caused by hemodialysis [ J ]. Clin Nephrol, 1999,51 (4) :242.
  • 8Tonbul HZ, Demir M, Ahintepe L, et al. Malnutrition - inflamma- tion - atherosclerosis(MIA) syndrome components in hemodialysis and peritoneal dialysis patients[ J]. Ren Fail ,2006,28 (4) :287.
  • 9Zhang L,Wang F,Wang L,et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012,379(9818) :815 -822.
  • 10Tomohito G, Hiromichi G, Mitsuo T, et al. Relationship between abdom- inal fat accumulation and insulin resistance in hemodialysis patient [ J ]. Hyperten Res, 2008, 32( 1 ) :83 -88.

引证文献6

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部